Expectations that GlaxoSmithKline will restart a share buyback programme in 2011 have risen with the sale of its stake in Quest Diagnostics for some £1.05bn.
Did you know with a Digital subscription to Yorkshire Post, you can get access to all of our premium content, as well as benefiting from fewer ads, loyalty rewards and much more.